Evidence map›Paper›PMID 30038565›Full record

ArticleFrontiers in aging neuroscience2018

Ca

Pradoldej Sompol, Christopher M Norris

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. CaMKII and CaCell biology and toxicology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pradoldej SompolSanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, United States.
Christopher M NorrisSanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, United States.
University of Kentucky · US

Funding

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's diseaseR01AG056998 · NIA · UNIVERSITY OF KENTUCKY · PI Elizabeth Head, Christopher Mark Norris · 2017 to 2026
$5.3M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseR01AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2006 to 2018
$3.2M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseRF1AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2018 to 2022
$2.6M
Astrocytic connexin 43 modulation in ADR21AG051945 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2017 to 2018
$414k
NIA NIH HHS R01 AG027297NIA NIH HHS R01 AG056998NIA NIH HHS R21 AG051945NIA NIH HHS RF1 AG027297
6 · The paper itself

Abstract

Mounting evidence supports a fundamental role for Ca

Indexed as

Alzheimer’s diseaseastrocytesCa2+dementiaglianeuroinflammationsynapse

Identifiers

PMID30038565
PMCPMC6046440
OpenAlexW2808363189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.